SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-007242
Filing Date
2021-03-30
Accepted
2021-03-30 17:30:19
Documents
92
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1737993
2 ex21-1.htm EX-21.1 9847
3 ex31-1.htm EX-31.1 16379
4 ex31-2.htm EX-31.2 16326
5 ex32.htm EX-32 6011
6 fin_001.jpg GRAPHIC 13953
  Complete submission text file 0001493152-21-007242.txt   7061781

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE yewb-20201231.xml EX-101.INS 1136853
8 XBRL SCHEMA FILE yewb-20201231.xsd EX-101.SCH 74023
9 XBRL CALCULATION FILE yewb-20201231_cal.xml EX-101.CAL 95273
10 XBRL DEFINITION FILE yewb-20201231_def.xml EX-101.DEF 281454
11 XBRL LABEL FILE yewb-20201231_lab.xml EX-101.LAB 527966
12 XBRL PRESENTATION FILE yewb-20201231_pre.xml EX-101.PRE 421519
Mailing Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Business Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731 626-401-9588
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54701 | Film No.: 21788398
SIC: 0100 Agricultural Production-Crops